PCN39 COSTS AT THE END OF LIFE FOR PATIENTS WITH CASTRATION-RESISTANT PROSTATE CANCER (CRPC)
May 1, 2011, 00:00 AM
10.1016/j.jval.2011.02.897
https://www.valueinhealthjournal.com/article/S1098-3015(11)01036-9/fulltext
Section Title :
Disease-Specific Studies
Section Order :
370
First Page :
A161
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(11)01036-9&doi=10.1016/j.jval.2011.02.897